Salbutamol oral - Recordati

Drug Profile

Salbutamol oral - Recordati

Alternative Names: Albuterol CRSS; Albuterol oral - Ascent Pediatrics; Albuterol oral - Recordati; Salbutamol CRSS; Salbutamol oral - Ascent Pediatrics; SCH 13949W oral - Ascent Pediatrics; SCH 13949W oral - Recordati

Latest Information Update: 07 Feb 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Recordati
  • Developer Medicis Pediatrics
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 07 Feb 2001 Discontinued-III for Asthma in USA (PO)
  • 27 Sep 1999 Phase III trials in asthma completed in the US
  • 06 Nov 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top